Current LDL-C management in Germany – The Victorion-implement study

Background and Aims: The VICTORION-Implement study aims to characterize the LDL-C management in patients with atherosclerotic cardiovascular disease (ASCVD) initiating a new oral lipid lowering therapy (LLT) or the PSCK9 siRNA inclisiran. The study assesses clinical characteristics, utilization of healthcare resources and patient reported outcomes.

Source: Atherosclerosis - August 1, 2023 Category: Cardiology Authors: O. Weing ärtner, U. Laufs, S. Lorkowski, B. Rauser, R. Etzl, V. Schettler Source Type: research